EUROAPI, a key name in the Active Pharmaceutical Ingredient (API) industry, has announced a significant leadership transition. Emmanuel Blin has been named Independent Chair of the Board of Directors, and David Seignolle assumes the role of Chief Executive Officer, both
EUROAPI has announced a five-year development and manufacturing agreement with Priothera, a biotechnology company focused on treatments for hematological malignancies and CAR-T cell therapies. This collaboration aims to develop and industrialize the manufacturing process of mocravimod, an innovative oncology molecule,
EUROAPI has been chosen by the European Commission as one of the 13 companies eligible to share up to €1 billion in public funding under the Important Project of Common European Interest (IPCEI) Med4Cure. The program, notified by six EU
EUROAPI has announced a strategic partnership with Spirochem, a Swedish contract research organisation. This collaboration is set to enhance EuroAPI’s contract development and manufacturing organisation (CDMO) capabilities, offering its customers a consolidated CRO-CDMO solution. The partnership comes at a time when the
EuroAPI Contract Manufacturing & Development (CDMO) Profile EUROAPI is the leading small molecules player with about 200 active pharmaceutical ingredients, offering one of the largest portfolios in the industry, while developing innovative molecules through CDMO activities CDMO Services: API and/or
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
